Dear Pharma World (at least the Derm world):
Your abbreviations are foreign to me. However, your gripes are not. I am intimately involved in the development of a lot of drugs that are coming soon.
I am a KOL, which means I am a PITA to all of you.
At AD boards we routinely discuss who we like to work with the most and which company has the best pipeline:
1. Eli Lilly - just shoots from every KOLs mouth. Great research team, amazing pipeline.IL-23, Baricitinib is a great drug, will Eventually get to market. Takes care of patients with samples. Two year free program.
2. Abbvie - Humira - its like it has t even been fair to the rest of the space, but it has slipped in share due to IL-17s, Otezla. Has a great pipeline. Knows how to treat the KOLs. Takes care of patient needs swiftly, great plan coverage samples the hell out of KOLs
3. Pfizer - not Eucrisa. Eucrisa is crap. But the Pfizer Derm pipeline is packed. Psoriasis, Eczema, Alope is Areata....
I hear they pay the reps well.
The losers.
Last Place
1. Regeneron - does not care about patients. No sampling. Crappy patient programs. Little coverage. Screwed up the patients program coming off the phase 3 trial. Screwed up data reporting and only dosing every other week unlike the trial which was weekly. Don't brain me with the data. I've read it. I just do t believe it. Parexel screwed up the trial so bad in so many ways, that it is no wonder that this is a crap launch.
History lesson: remember alefacept - the first biologic for Psoriasis.
Oh, yeah, where's the pipeline?
2. Novartis - at least the drug is great and patients safe taken care of. The rest of the comoany sucks.! Poor KOL relations, do not take our advice, crappy research division.
Oh, yeah, where's the pipeline in Derm? Did you forget something? The Ziarco atopic drug sucks. Can anyone at Novartis interpret data?